Beruflich Dokumente
Kultur Dokumente
Medicine or
Physiology 2005
Barry James Marshall (Australian
Gastroenterologist)
John Robin Warren (Australian Pathologist)
http://3.bp.blogspot.com/-EvJS2yt55w/URPEPG8WuvI/AAAAAAAAKkk/4aWpOhiGKQ/s1600/Barry+Marshall.jpg
http://4.bp.blogspot.com/CUVuKoG3Wrw/URPDG13jK2I/AAAAAAAAKkc/ginik587PMs/
s1600/Robin+Warren.jpg
of
Helicobacter pylori
Its Role in Gastritis and Peptic Ulcer Disease
What is Helicobacter
pylori?
Spiral-shaped, gram-negative,
microaerophilic (need low level
of O2) bacterium
Class 1
cancer)
carcinogen
(induce
H pylori in 20 century
th
Discovery of H. pylori by
Marshall and Warren
1979, Warren discovered the bacteria on a chronic gastritis biopsy
using Warthin-Starry silver stainsmall curved, spiral bacteria were
observed!
1982, Marshall and Warren studied to determine the relationship
between H. pylori and PUD and a new genus of helicobacter was
successfully cultured.
1984, Marshall intentionally consumed H. pylori after failing to infect
pigs. Then he used antibiotics to relieve his symptoms.
1985, Marshall published the results of self-induced infection in MJA.
1987, NEJM published a study on H. pylori which agrees on their
discovery
1989, Warren developed the 14C-urea breath test for the detection of
gastric Campylobacter pylori infection, and was published in MJA.
1994, WHO accepted that H. pylori as a causative factor in stomach
cancer.
Problems with
researching H. pylori
Skepticism
Lack of good quality biopsies
Use of surgical or post mortem
specimens
Inadequate clinical specimens and
technology to culture bacteria
Impact of discovery
towards current medical
practice
http://www.faseb.org/portals/2/pdfs/opa/pylori.pdf
Impact of discovery
towards current research
Made H. pylori infection one of the most
studied paradigms of pathogen biology
1. Listed as carcinogen associated with
gastric carcinoma and MALT lymphoma
2. Association with other conditions
3. Further research; genomic diversity,
pathogenicity, mechanism, development of
urea breath test
Whats next?
Antibiotic resistance
Metronidazole
In U.S., Clarithromycin resistance is found in
20% of H. pylori positive patients
Possible Future
Development
Changing epidemiology of upper gastrointestinal
diseases (peptic ulceration, oesophageal and gastric
adenocarcinoma, gastro-oesophageal reflux disease
and sequelae) with changing prevalence of colonisation
with Helicobacter pylori
Recognition of host factors that predispose to diseases
induced by H pylori
Definition of genetic characteristics of H pylori that are
associated with significant variance in risk of disease
Vaccinations against certain diseases based on specific
interactions between H pylori and host
Colonisation of some hosts with strains of H pylori with
low virulence to reduce risk of particular diseases
Possible Future
Development
In 1989, Strachan proposed the hygiene
hypothesis, stating that the exposure to infectious
agents and living in an unhygienic environment
might educate the immune system and thus
protect against the development of allergic diseases.
Ondek has created and patented a derivative of H.
pylori that has retained its immune regulatory
properties to combat the escalating problem of
allergy.
Current targets are eczema, food allergies and
allergic asthma.
Further research to target more allergic reactions.
References:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047919/
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1113159/
http://ondek.com/our-approach/
http://www.nobelprize.org/nobel_prizes/medicine/laurea
tes/2005
/
http://www.ncbi.nlm.nih.gov/books/NBK2432/.
http://
www.nobelprize.org/nobel_prizes/medicine/laureates/200
5/marshall-lecture.pdf
http://www.ncbi.nlm.nih.gov/pubmed/2593958
http://www.ncbi.nlm.nih.gov/pubmed/3335917
https://
www.science.org.au/teacher-notes-dr-robin-warren
http://www.faseb.org/portals/2/pdfs/opa/pylori.pdf